Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

SELF-TEST FOR HUMAN CHORIONIC GONADOTROPIN (HCG) - ANVISA Registration 81602800014

Access comprehensive regulatory information for SELF-TEST FOR HUMAN CHORIONIC GONADOTROPIN (HCG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81602800014 and manufactured by HUBEI MEIBAO BIOTECHNOLOGY CO., LTD.. The registration is held by GRUPO MULTI S.A with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, ALAMAR TECNO CIENTÍFICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
81602800014
Registration Details
ANVISA Registration Number: 81602800014
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Registration Details

81602800014

25351725911202399

59717553000617

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Nov 27, 2023

VIGENTE

09/18/2025 19:00:01